High levels of geographic mobility in and out of HIV care centres (i.e. the churn effect) can disrupt the continuity of patient care, misalign prevention services, impact local prevalence data perturbing optimal allocation of resources, and contribute to logical challenges in repeated transfer of health records. We report on the clinical, demographic, and administrative impact of high population turnover within HIV populations.
AgeeBS, FunkhouserE, RosemanJM, FawalH, HolmbergSD, WermundSH. Migration patterns following HIV diagnosis among adults residing in the nonurban Deep South. AIDS Care2006;18(Suppl. 1):S51–8
2.
BerkML, SchurCL, DunbarJL, BozzetteS, ShapiroM. Short report: migration among persons living with HIV. Soc Sci Med2003;57:1091–7
3.
CohnS, KleinJD, MohrJE, wan der HorstCM, WeberDJ. The geography of AIDS: patterns of urban and rural migration. S Med J1994;87:599–606
4.
EllisM, MuschkinC. Migration of persons with AIDS – a search for support from elderly patients?Soc Sci Med1996;43:1109–18
5.
HoggRS, SchechterMT, SchilderA, Access to health care and geographic mobility of HIV/AIDS patients. AIDS Patient Care1995;9:297–302
6.
TatumPS, SchoechD. Migration of persons with HIV Disease: the search for care. AIDS Public Policy J1992;7:56
7.
WoodE, YipB, GataricN, Determinants of geographic mobility among participants in a population-based HIV/AIDS drug treatment program. Health Place2000;6:33–40
8.
BuehlerJW, FreyRL, ChuSY. The migration of persons with AIDS: data from 12 states, 1985 to 1992. AIDS Mortality Project Group. Am J Public Health1995;85:1552–5
9.
DavisK, StapletonJ. Migration to rural areas by HIV patients: impact on HIV-related use. Infect. Control Hosp. Epid1991;12:540–3
10.
LanskyA, NakashimaAK, DiazT, Human immunodeficiency virus infection in rural areas and small cities of the southeast: contribution of migration and behaviour. J Rural Health2000;16:20–30
11.
QuinnT. Population migration and the spread of types 1 and 2 human immunodeficiency viruses. Proc Natl Acad Sci USA1994;91:2407–14
12.
DerenS, KangSY, ColonHM, Migration and HIV risk behaviour: Puerto Rican drug injectors in New York City and Puerto Rico. Am J Public Health2003;93:812–6
13.
JohnsonTP, VanGreestJB, ChoYI. Migration and substance abuse: evidence from the US national health interview survey. Sust Use Misue2002;37:941–72
14.
RachlisB, BrouwerKC, MillsEJ, HayesM, KerrT, HoggRS. Migration and transmission of blood-borne infection among injection drug users: Understanding the epidemiologic bridge. Drug Alcohol Depend2007;90:107–19
15.
ShedlinMG, DruckerE, DecenaCU, Immigration and HIV/AIDS in the New York metropolitan area. J Urban Health2006;83:43–58
16.
CartwrightCP. The changing epidemiology of HIV/AIDS at a Minnesota Hospital: impact of demographic change and viral diversity. J Med Virol2006;78:S19–21
17.
Del AmoJ, BroringG, HamersFF, InfusoA, FentonK. Monitoring HIV/AIDS in Europe's migrant communities and ethnic minorities. AIDS2004;18:1868–73
18.
GushulakBD, MacPhersonDW. The impact of population movement on the epidemiology of HIV/AIDS in Europe. In: MaticS, LazarusJV, Donoghoe,MC, eds. HIV/AIDS in Europe. Moving From Death Sentence To Chronic Disease Management, 2005 ISBN 92-890-2284-1
19.
HamersFF, DownAM. The changing face of the HIV epidemic in Western Europe: what are the implications for public health policies?Lancet2004;364:83–94
20.
SinkaK, MortimerJ, EvansB, MorganD. Impact of the HIV epidemic in sub-Saharan Africa on the pattern of HIV in the UK. AIDS2003;17:1683–90
21.
ManfrediR, CalzaL, ChiodoF. HIV-infected immigrants from non-European union countries and antiretroviral treatment: comparison of epidemiologic, clinical, and theraeutic variables according to patient sex. JAIDS2003;33:408–10
22.
StaehelinC, EgloffN, RickenbachM, KoppC, FurrerHthe Swiss HIV Cohort Study. Migrants from sub-Saharan Africa in the Swiss HIV Cohort Study: a single center study of epidemiologic migration-specific and clinical features. AIDS Patient Care STDs2004;18:665–75
23.
KrentzHB, GillMJ. The five-year impact of an evolving global epidemic, changing migration patterns, and policy changes on a regional Canadian HIV population. Health Policy2009;90:296–302
24.
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use Of Antiretroviral Agents In Hiv-1-Infected Adults And Adolescents. Department of Health and Human Services. January 29, 2008; 1–128. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf (accessed 18 June 2008), Page 32
25.
HoggRS, WhiteheadJ, RickettsM, Patterns of geographic mobility of persons with AIDS in Canada from the time of AIDS index diagnosis to death. Clin Invest Med1997;20:77–84
26.
LanoyE, Mary-KrauseM, TattevinP, Predictors identified for losses to follow-up among HIV-seropositive patients. J Clin Epidemiol2006;59:829–35
27.
CallaghanRC, TavaresJ, TaylorL. Mobility patterns of aboriginal injection drug users between and off-reserve settings in northern British Colombia, Canada. Int J Circumpolar Health2007;66:241–7
28.
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group CD4+ Count-Guided interruption of antiretroviral treatment. N Engl J Med2006;355:2283–96
29.
KrentzHB, GillMJ. Clinical, demographic, and health resource utilization characteristics of hiv-infected sub-saharan immigrants and refugees followed at the Southern Alberta clinic. Can J Infect Dis Med Microbiol. 16, (Suppl. A) March/April 2006; Abstract #255P
